Advertisement

Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug.

Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug.

The company is trying to carve a niche in a rapidly growing obesity-drug market that’s currently dominated by Eli Lilly and Novo Nordisk.